Resource Center
Drugs to Watch 2026
Your central destination for identifying the treatments poised to transform patient care. Explore our flagship report, deep-dive webinars, and expert insights to understand the blockbusters and disruptors shaping the life sciences industry.
Drugs to Watch 2026
Your central destination for identifying the treatments poised to transform patient care. Explore our flagship report, deep-dive webinars, and expert insights to understand the blockbusters and disruptors shaping the life sciences industry.
Get the complete 2026 analysis
Access exclusive analyst insights, early pipeline visibility, and clear explanations of the scientific and commercial factors driving the future of medicine.
- ✓ 11+ potential blockbusters identified
- ✓ Deep-dive therapeutic area analysis
- ✓ Commercial and regulatory outlooks
Webinar series library
Dive deeper into the therapeutic areas shaping the future of healthcare. Watch our expert analysts break down the data on-demand.
Navigating the next wave of GLP‑1 evolution and beyond
Explore the $150bn obesity market as our analysts discuss the metabolic revolution, oral vs. injectable innovation trends, next-generation clinical breakthroughs, and long-term sustainability challenges.
Featured drug spotlights
Four transformative therapies reshaping chronic and rare disease management
Discover how transformative therapies are altering care pathways for rare diseases by expanding treatment paradigms, improving patient impact, and navigating complex regulatory hurdles for small patient populations.
Featured drug spotlights
Reshaping oncology therapeutic strategy through targeted protein degradation
Learn how targeted protein degradation (TPD) provides new approaches to difficult-to-treat cancers through deep dives into pivotal clinical data, competitive positioning strategies, and long-term commercial forecasting.
Featured drug spotlights
Women’s health: Innovations driving better solid tumor outcomes
Join our analysts to uncover how precision therapeutics are finally transforming breast, ovarian, and bladder cancer outcomes by overcoming historical paradigms and driving durable commercial success.
Featured drug spotlights
Related articles & insights
Stay up to date with the latest analyses and market trends from our thought leadership team.